Affimed's Preclinical Data Demonstrates the Therapeutic Potential of AFM24 in EGFR-expressing Tumors

EVI to lead Inno4vac, a new European public-private partnership to innovate vaccine development

Vaccination against hereditary colorectal cancer successful in mice

The potential of the immune system to restore patients’ innate ability to fight cancer

Spotlight on Internationalisation

New druggable vulnerabillty of colorectal cancer discovered

Biocair opens new office in South Africa, a clinical research hub

Biopharmaceuticals are the treasures of biotechnology

Nose2Brain – Active substances without detour through the nose into the brain

Merck Invests € 270 Million in a New Research Center and Vocational & Advanced Training in Darmstadt

Heidelberg Pharma Allowed to Start a Phase I/IIa Clinical Trial with ATAC Candidate HDP-101

A model of cooperation for transporting mRNA

Hijacked immune activator promotes growth and spread of colorectal cancer

Searching for clues with cytogenetics and AI

Ascendis Pharma announces target enrollment achieved in the phase 3 PaTHway trial of TransCon PTH

New insights into Salmonella’s survival strategies

CORAT Therapeutics GmbH announces partnership with Dermapharm Holding SE

Viscofan BioEngineering submits MAF for medical grade Viscolma collagen suspension

High-throughput metabolic profiling of single cells

Spotlight on Internationalisation